Stage IVB Prostate Cancer AJCC v8 Recruiting Phase 3 Trials for Apalutamide (DB11901)

IndicationStatusPhase
DBCOND0109404 (Stage IVB Prostate Cancer AJCC v8)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04423211Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingTreatment